“…5,[10][11][12] Finally, other researchers found no evidence that inoculation of mice with TLR ligands led to meaningful activation of memory B cells in vivo. [19][20][21] In mice, plasma cell subsets of varying lifespans can be distinguished by expression of B220, B-lymphocyte induced maturation protein 1 (BLIMP1), CD93 (also known as AA4.1), major histocompatibility class 2 (MHCII), CXCR3, and uptake of the fluorescent glucose analog 2-deoxy-2-(7-Nitro-2,1,3-benzoxadiazol-4-yl)amino)-D-glucose (2NBDG) 1,[22][23][24][25] (Figure 1). Thus, in the context of the findings by Amanna and colleagues, we conclude that the different half-lives of antibody production after vaccination or infection are due to heterogeneity in the lifespan of the plasma cells.…”